ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/01 | 2,060 | 2,105 | 2,050 | 2,100 | +66 | +3.2% | 97,600 |
2021/10/29 | 2,003 | 2,034 | 2,003 | 2,034 | +52 | +2.6% | 46,800 |
2021/10/28 | 2,011 | 2,028 | 1,982 | 1,982 | -34 | -1.7% | 66,400 |
2021/10/27 | 2,035 | 2,035 | 2,014 | 2,016 | -14 | -0.7% | 22,300 |
2021/10/26 | 2,022 | 2,034 | 2,016 | 2,030 | +20 | +1% | 16,300 |
2021/10/25 | 2,019 | 2,038 | 2,000 | 2,010 | -24 | -1.2% | 28,300 |
2021/10/22 | 2,000 | 2,049 | 1,999 | 2,034 | +14 | +0.7% | 27,900 |
2021/10/21 | 2,019 | 2,029 | 2,010 | 2,020 | -7 | -0.3% | 20,700 |
2021/10/20 | 2,034 | 2,041 | 2,016 | 2,027 | +2 | +0.1% | 29,100 |
2021/10/19 | 2,037 | 2,047 | 2,022 | 2,025 | -15 | -0.7% | 23,200 |
2021/10/18 | 2,050 | 2,056 | 2,020 | 2,040 | -5 | -0.2% | 29,400 |
2021/10/15 | 2,025 | 2,050 | 2,010 | 2,045 | +36 | +1.8% | 46,800 |
2021/10/14 | 2,010 | 2,010 | 1,994 | 2,009 | -7 | -0.3% | 29,000 |
2021/10/13 | 2,030 | 2,030 | 2,016 | 2,016 | -12 | -0.6% | 34,400 |
2021/10/12 | 2,026 | 2,032 | 2,010 | 2,028 | -10 | -0.5% | 32,700 |
2021/10/11 | 2,022 | 2,038 | 2,006 | 2,038 | +23 | +1.1% | 24,600 |
2021/10/08 | 1,997 | 2,024 | 1,993 | 2,015 | +35 | +1.8% | 46,700 |
2021/10/07 | 1,974 | 1,989 | 1,968 | 1,980 | +6 | +0.3% | 41,500 |
2021/10/06 | 1,968 | 2,000 | 1,962 | 1,974 | ±0 | ±0% | 56,100 |
2021/10/05 | 2,003 | 2,012 | 1,966 | 1,974 | -48 | -2.4% | 76,300 |
2021/10/04 | 2,015 | 2,028 | 2,004 | 2,022 | +16 | +0.8% | 51,300 |
2021/10/01 | 2,043 | 2,043 | 2,000 | 2,006 | -53 | -2.6% | 75,700 |
2021/09/30 | 2,054 | 2,080 | 2,047 | 2,059 | +2 | +0.1% | 49,900 |
2021/09/29 | 2,072 | 2,072 | 2,036 | 2,057 | -59 | -2.8% | 93,000 |
2021/09/28 | 2,142 | 2,145 | 2,088 | 2,116 | -26 | -1.2% | 165,600 |
2021/09/27 | 2,191 | 2,191 | 2,142 | 2,142 | -31 | -1.4% | 82,500 |
2021/09/24 | 2,160 | 2,191 | 2,156 | 2,173 | +49 | +2.3% | 125,000 |
2021/09/22 | 2,181 | 2,182 | 2,124 | 2,124 | -59 | -2.7% | 63,100 |
2021/09/21 | 2,193 | 2,196 | 2,166 | 2,183 | -27 | -1.2% | 71,000 |
2021/09/17 | 2,214 | 2,221 | 2,190 | 2,210 | +3 | +0.1% | 106,600 |
2021/09/16 | 2,192 | 2,207 | 2,161 | 2,207 | +25 | +1.1% | 66,500 |
2021/09/15 | 2,203 | 2,203 | 2,177 | 2,182 | -44 | -2% | 46,900 |
2021/09/14 | 2,208 | 2,226 | 2,198 | 2,226 | +19 | +0.9% | 65,700 |
2021/09/13 | 2,180 | 2,209 | 2,166 | 2,207 | +31 | +1.4% | 53,800 |
2021/09/10 | 2,142 | 2,176 | 2,142 | 2,176 | +20 | +0.9% | 76,900 |
2021/09/09 | 2,183 | 2,190 | 2,151 | 2,156 | -43 | -2% | 53,400 |
2021/09/08 | 2,203 | 2,212 | 2,190 | 2,199 | +2 | +0.1% | 43,600 |
2021/09/07 | 2,200 | 2,210 | 2,182 | 2,197 | +3 | +0.1% | 54,600 |
2021/09/06 | 2,205 | 2,206 | 2,176 | 2,194 | ±0 | ±0% | 38,700 |
2021/09/03 | 2,150 | 2,200 | 2,150 | 2,194 | +55 | +2.6% | 59,600 |
2021/09/02 | 2,172 | 2,179 | 2,134 | 2,139 | -30 | -1.4% | 51,300 |
2021/09/01 | 2,165 | 2,180 | 2,161 | 2,169 | +7 | +0.3% | 31,100 |
2021/08/31 | 2,160 | 2,186 | 2,151 | 2,162 | -4 | -0.2% | 41,000 |
2021/08/30 | 2,145 | 2,171 | 2,142 | 2,166 | +27 | +1.3% | 26,100 |
2021/08/27 | 2,200 | 2,200 | 2,134 | 2,139 | -73 | -3.3% | 64,000 |
2021/08/26 | 2,210 | 2,213 | 2,181 | 2,212 | +3 | +0.1% | 43,600 |
2021/08/25 | 2,181 | 2,217 | 2,157 | 2,209 | +25 | +1.1% | 61,000 |
2021/08/24 | 2,188 | 2,194 | 2,167 | 2,184 | -1 | ±0% | 69,200 |
2021/08/23 | 2,147 | 2,194 | 2,147 | 2,185 | +49 | +2.3% | 66,200 |
2021/08/20 | 2,129 | 2,140 | 2,124 | 2,136 | +19 | +0.9% | 59,900 |
751~
800
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム